Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold.

Clinical endocrinology - 1 Dec 2017

Quinn Molly M, Kao Chia-Ning, Ahmad Asima K, Haisenleder Daniel J, Santoro Nanette, Eisenberg Esther, Legro Richard S, Cedars Marcelle I, Huddleston Heather G

Abstract excerpt

OBJECTIVE: Due to its consistent elevation in polycystic ovary syndrome (PCOS) and correlation with polycystic ovarian morphology (PCOM), anti-Mullerian hormone (AMH) has been proposed as a marker of the syndrome. However, prior studies reporting thresholds of AMH for a PCOS diagnosis have been limited by small sample size, inappropriate controls, and heterogeneous AMH assays. We sought to evaluate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Anti-Mullerian Hormone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biological Assay

Share to AMH gene

Share to Phenotype

Share to Polycystic Ovary Syndrome

Source

Identifiers

PMID: 28681949
DOI: 10.1111/cen.13415

Genes

AMH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold.PMID 28681949Read ↗

AMH levels and diagnosis in PCOS phenotype D.Semantic proximity Read ↗

The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.Semantic proximity Read ↗

The Diagnostic Performance of Antimullerian Hormone for Polycystic Ovarian Syndrome and Polycystic Ovarian MorphologySemantic proximity Read ↗

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.Semantic proximity Read ↗

The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.Semantic proximity Read ↗

Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndromeSemantic proximity Read ↗

Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in JapanSemantic proximity Read ↗

Demographic, clinical characteristics, polycystic ovarian syndrome phenotypes and predictors of anti-mullerian hormone among women with PCOS at a Fertility Center in Ghana: A 5-year retrospective studySemantic proximity Read ↗

Antimullerian Hormone Levels by Phenotypes in Polycystic Ovary Syndrome: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Polycystic ovary syndrome v.2023: Simplified diagnostic criteria for an East Asian phenotype.Semantic proximity Read ↗

Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary SyndromeSemantic proximity Read ↗

The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.